PEN
Penumbra Inc
NYSE · Healthcare · Medical - Devices · US
$317.60
−0.40%Forward multiples
Based on analyst estimates
- P/E forward
- 57.29x
- P/E 2026E
- 67.59x
- P/E 2027E
- 53.13x
- P/E 2028E
- 45.55x
- P/S forward
- 7.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- 77.65x
- PEG TTM
- 2.19x
- Price / book
- 8.17x
- Price / sales
- 8.31x
- Price / cash flow
- 45.03x
Enterprise value
- Enterprise value
- $12.1B
- EV / sales
- 8.02x
- EV / EBITDA
- 54.28x
- EV / EBIT
- 64.39x
- Market cap
- $12.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026